Colon and Rectal Cancer

• ESMO Preceptorship on Colorectal Cancer Lugano November 2019
• Clinical case
• The viewpoint of an Interventional radiologist
• Minimal residual disease (overview lecture)
• Data-driven miRNA classifier as response predictor for immune checkpoint inhibitor treatment in advanced-stage cancer patients
• The clinical usefulness of a new fat-dissociation method to detect lymph nodes from surgically resected specimen in colorectal cancer: Prospective...
• Concurrent or consolidation chemotherapy during radiation as neoadjuvant treatment for locally advanced rectal cancer: A propensity score analysis...
• Body mass index, tumour location, and colorectal cancer survival
• Helicobacter bilis may play a role in the carcinogenesis of colitis associated colon cancer correlating to increased number of CD4+CD45RB+ T cells
• Comprehensive evaluation of relapse risk (CERR) score for colorectal liver metastases development and validation
• Which is the best partner for capecitabine-based neoadjuvant chemoradiotherapy in locally advanced rectal cancer? A retrospective analysis of a com...
• Negative to positive lymph node ratio-prognostic marker of survival in node positive rectal cancer
• The Sidra LUMC advanced colon cancer NGS cohort
• A phase II trial of adjuvant chemoradiotherapy for patients with high-risk rectal submucosal invasive cancer after local resection
• High MICB expression confers prognostic benefit in colorectal cancer
• Adjuvant therapy for high-risk stage II or stage III colon adenocarcinoma: A propensity score-matched, nationwide, population-based cohort study
• Biomarker selection of liver metastatic colorectal patients for anti-EGFR monoclonal antibodies: A machine learning analysis
• NORTH/HGCSG1003: North Japan multicenter phase II study of oxaliplatin-containing regimen as adjuvant chemotherapy for stage III colon cancer: Fina...
• Anatomical resections improve relapse-free survival in patients with KRAS/NRAS/BRAF- mutated colorectal liver metastases
• Incidence, characteristics and prognosis in colorectal cancer with CNS metastases
• The role of adjuvant chemotherapy according to the status of surgical margin in rectal cancer
• Influence of DPYD*9, DPYD*6 and GSTP1 ile105val genetic polymorphisms on capecitabine and oxaliplatin (CAPOX) associated toxicities in colorectal c...
• Clinical impact and carcinogenic mechanism of NCAPG overexpression in colon cancer
• Combined cellular immunotherapy and chemotherapy improves clinical outcome and displays safety in the treatment of patients with colorectal cancer
• Clinical features of anorectal cancer in patients with Crohn’s disease: Japanese single center study

• « Previous
• 1
• 2
• ...
• 67
• Next »